J. Belleroche

发表

Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function

M. Barnes, P. Maycox, M. Lennon, 2009, Molecular Psychiatry.

Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression

M. Akbar, J. Belleroche, D. Latchman, 2008, Neurobiology of Disease.

Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis

J. Belleroche, R. Orrell, R. Lane, 1995, Journal of the Neurological Sciences.

Spinal cord molecular profiling provides a better understanding of Amyotrophic Lateral Sclerosis pathogenesis

J. Belleroche, A. Malaspina, 2004, Brain Research Reviews.

Amyotrophic Lateral Sclerosis: Recent Advances in Understanding Disease Mechanisms

J. Belleroche, R. Orrell, L. Virgo, 1996, Journal of neuropathology and experimental neurology.

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

Timothy A. Miller, Jennifer E. Phillips-Cremins, Lilah M. Besser, 2020, Neuron.

In Situ Hybridization: Medical Applications

J. Belleroche, G. Coulton, 1992, Springer Netherlands.

Heat shock protein 27 protects the heart against myocardial infarction

J. Belleroche, M. Mocanu, D. Yellon, 2004, Basic Research in Cardiology.

Synaptophysin in spinal anterior horn in aging and ALS: an immunohistological study

E. Tolosa, J. Belleroche, F. cruz-Sánchez, 2005, Journal of Neural Transmission.

Mutations in ANXA11 cause familial and sporadic amyotrophic lateral sclerosis

F. Baas, J. Belleroche, A. Al-Chalabi, 2017 .

Title: Mutations in ANXA11 cause familial and sporadic amyotrophic lateral sclerosis

Robert H. Brown, M. Weale, F. Baas, 2016 .

Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine

J. Belleroche, T. Murphy, P. Paul, 2014, Neurobiology of Aging.

Acetylcholine-Dopamine Interactions in the Corpus Striatum and Nucleus Accumbens

J. Belleroche, 1982 .

Dopamine Inhibition of the Release of Endogenous Acetylcholine from Corpus Striatum and Cerebral Cortex in Tissue Slices and Synaptosomes: A Presynaptic Response?

J. Belleroche, H. Bradford, J. Coutinho‐Netto, 1982, Journal of neurochemistry.

PHENOTYPIC HETEROGENEITY AND SIMILARITIES WITH SPORADIC ALS

J. Belleroche, R. Orrell, 2022 .

Facilitation of GABA release by cholecystokinin and caerulein in rat cerebral cortex

J. Belleroche, M. Sheehan, 1983, Neuropeptides.

Increased Polyphosphoinositide Responsiveness in the Cerebral Cortex Induced by Cholinergic Denervation

J. Belleroche, L. Reed, 1988, Journal of neurochemistry.

Effect of lesion of the nucleus basalis of rat on acetylcholine release in cerebral cortex: time course of compensatory events

I. M. Gardiner, J. Belleroche, I. Gardiner, 1987, Brain Research.

Elevated platelet phoshatidylinositol bisphosphate in medicated schizophrenics

S. Hirsch, J. Belleroche, I. Das, 1994, Schizophrenia Research.

Title: Mutations in ANXA11 cause familial and sporadic amyotrophic lateral sclerosis

Robert H. Brown, M. Weale, F. Baas, 2016 .

A novel mutation of SOD‐1 (Gly 108 Val) in familial amyotrophic lateral sclerosis

J. Belleroche, R. Orrell, D. Donnai, 1997, European journal of neurology.

Characterisation of the distribution of choline acetyltransferase messenger RNA in human spinal cord and its depletion in motor neurone disease

J. Belleroche, T. Steiner, L. Virgo, 1992, Journal of the Neurological Sciences.

Endoplasmic Reticulum (ER) Stress in Amyotrophic Lateral Sclerosis (ALS)

J. Belleroche, Han-Jou Chen, 2012 .

Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB

J. Belleroche, A. Morris, C. Kwok, 2013, European Journal of Human Genetics.

Ciliary Neurotrophic Factor (CNTF): Possible Implications in the Pathogenesis of Amyotrophic Lateral Sclerosis

J. Belleroche, R. Orrell, R. Lane, 1996 .

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Timothy A. Miller, Sonja W. Scholz, Jennifer E. Phillips-Cremins, 2020, Neuron.

Mice that overexpress human heat shock protein 27 have increased renal injury following ischemia reperfusion.

J. Belleroche, V. D’Agati, S. Park, 2009, Kidney international.

Leukotriene B4 Generation by Polymorphonuclear Leukocytes: Possible Involvement in the Pathogenesis of Headache

J. Belleroche, K. Selmaj, F. Rose, 1986, Headache.

An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4

J. Belleroche, J. Collinge, N. Katsanis, 1995 .

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic

Timothy A. Miller, Denis C. Bauer, Shankaracharya, 2018 .

Differential Changes in Receptor‐Mediated Transduction in Migraine and Cluster Headache: Studies on Polymorphonuclear Leucocytes

J. Belleroche, F. Rose, P. Davies, 1988, Headache.

Cellular Adaptation in Migraineurs with Chronic Daily Headache

J. Belleroche, T. Steiner, T. Catarci, 1993, Cephalalgia : an international journal of headache.

The platelet polyphosphoinositide system in Schizophrenia: The effects of neuroleptic treatment

S. Hirsch, J. Belleroche, I. Das, 1990, Biological Psychiatry.

Induction of Ornithine Decarboxylase in Cerebral Cortex by Excitotoxin Lesion of Nucleus Basalis: Association with Postsynaptic Responsiveness and N‐Methyl‐d‐Aspartate Receptor Activation

J. Belleroche, L. Reed, 1990, Journal of neurochemistry.

Induction of ornithine decarboxylase mRNA in cerebral cortex in response to kainate lesion of nucleus basalis: involvement of NMDA receptors

J. Belleroche, H. Wood, 1990, Neuroscience Letters.

Action of apomorphine, bromocriptine and lergotrile onγ-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum

J. Belleroche, I. Gardiner, 2005, Journal of Neural Transmission.

Regulation of CCK release in cerebral cortex by N-methyl-D-aspartate receptors: Sensitivity to APV, MK-801, kynurenate, magnesium and zinc lons

J. Belleroche, R. Bandopadhyay, 1991, Neuropeptides.

The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat

J. Belleroche, L. J. Herberg, M. Sheehan, 1984, Neuroscience Letters.

The synaptosome: An isolated, working, neuronal compartment

J. Belleroche, H. Bradford, 1973 .

Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals

J. Belleroche, H. Bradford, 1978, Brain Research.

Glycine and neurodegenerative disease

J. Belleroche, J. Dick, RussellJ. M. Lane, 1991, The Lancet.

Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: Sensitisation by naloxone

J. Belleroche, M. Rattray, 1987, Neuropeptides.

Caerulein-induced antinociception: Interaction with morphine and opioid antagonists in the rat

J. Belleroche, M. Rattray, C. Jordan, 1989, Neuropeptides.

Increased CSF amino acids and ventricular enlargement in schizophrenia: A preliminary study

S. Hirsch, J. Belleroche, M. Reveley, 1987, Biological Psychiatry.

Evidence for time dependence of morphine effects on cholecystokinin release from rat periaqueductal grey

J. Belleroche, M. Rattray, 1988 .

Quantitation of cholecystokinin mRNA in the rat brain by slot-blotting and northern analysis: Preliminary studies on the effect of acute morphine

J. Belleroche, M. Rattray, 1986, Regulatory Peptides.

Genome-wide Analyses Id entify KIF 5 A as a Novel ALS Gene Highlights

Sonja W. Scholz, Janel O. Johnson, D. Hernandez, 2018 .

VCP mutations are not a major cause of familial amyotrophic lateral sclerosis in the UK

J. Belleroche, C. Shaw, A. Morris, 2015, Journal of the Neurological Sciences.

Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord

C. Angelinetta, M. Akbar, J. Belleroche, 2010, Neurobiology of Aging.

Common variants in the chromosome 2p23 region containing the SLC30A3 (ZnT3) gene are associated with schizophrenia in female but not male individuals in a large collection of European samples

P. McKenna, P. McKenna, A. Mortimer, 2016, Psychiatry Research.

Regional distribution of cholecystokinin messenger RNA in rat brain during development: Quantitation and correlation with cholecystokinin immunoreactivity

J. Belleroche, R. Bandopadhyay, A. Rashid, 1990, Neuropeptides.

Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays.

J. Belleroche, A. Malaspina, N. Kaushik, 2001 .

Application of in situ hybridization to studies of messenger RNA in the nervous system: functional correlations and their quantitation

J. Belleroche, L. Virgo, A. Rashid, 1992 .

Induction of c-fos mRNA in cerebral cortex by excitotoxin stimulation of cortical inputs: involvement ofN-methyl-d-aspartate receptors

J. Belleroche, H. Wood, 1991, Brain Research.

A 14‐3‐3 mRNA Is Up‐Regulated in Amyotrophic Lateral Sclerosis Spinal Cord

J. Belleroche, A. Malaspina, N. Kaushik, 2000, Journal of neurochemistry.

An integrated map of chromosome 18 CAG trinucleotide repeat loci

K. Lindblad, F. Baas, J. Belleroche, 1999, European Journal of Human Genetics.

A survey of trinucleotide/tandem repeat-containing transcripts (TNRTs) isolated from human spinal cord to identify genes containing unstable DNA regions as candidates for disorders of motor function

J. Belleroche, A. Malaspina, Jackie de Belleroche, 2001, Brain Research Bulletin.

Molecular basis of addiction

J. Belleroche, W. Caan, 2002 .

Abnormal Membrane Composition and Membrane-Dependent Transduction Mechanisms in Cluster Headache

J. Belleroche, S. Kilfeather, F. Rose, 1986, Cephalalgia : an international journal of headache.

Modulation of γ‐Aminobutyric Acid Release in Cerebral Cortex by Fluoride, Phorbol Ester, and Phosphodiesterase Inhibitors: Differential Sensitivity of Acetylcholine Release to Fluoride and K+ Channel Blockers

J. Belleroche, I. Gardiner, 1990, Journal of neurochemistry.

Smoking: addiction to nicotine

J. Belleroche, W. Caan, 2002 .

The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder

Michelle K. Lupton, T. Hortobágyi, Robert H. Brown, 2012, European Journal of Human Genetics.

Identification of genetic heterogeneity in Refsum's disease

J. Belleroche, A. Wierzbicki, J. Mitchell, 2000, European Journal of Human Genetics.

Identification of a second locus for Refsum's disease at chromosome 6p22-24

J. Belleroche, A. Wierzbicki, M. Feher, 2000 .

UvA-DARE ( Digital Academic Repository ) Identification of PEX 7 as the second gene involved in Refsum disease

J. Belleroche, H. Waterham, R. Wanders, 2003 .

ChapterChapter 2 IDENTIFICATIO NN OF PEX 7 AS THE SECOND GENE INVOLVE DD IN REFSUM DISEASE

J. Belleroche, R. Wanders, J. Haasjes, 2008 .

Evidence for presynaptic cholinergic receptors on dopaminergic terminals: Degeneration studies with 6-hydroxydopamine

J. Belleroche, H. Bradford, Y. Lugmani, 1979, Neuroscience Letters.

On the Metabolic and Intrasynaptic Origin of Amino Acid Transmitters

J. Belleroche, H. Bradford, H. K. Ward, 1978 .

Differential amino acid neurotransmitter release in rat neostriatum following lesioning of the cortico-striatal pathway

J. Belleroche, H. Bradford, D. Peterson, 1982, Brain Research.

Metabolic Abnormality in Cluster Headache

J. Belleroche, F. Rose, I. Das, 1984, Headache.

Heat shock protein 27 rescues motor neurons following nerve injury and preserves muscle function

J. Belleroche, D. Wells, P. Sharp, 2006, Experimental Neurology.

The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function

J. Belleroche, B. Costall, R. Naylor, 1987, Psychopharmacology.

Regulation of the platelet polyphosphoinositide system by antipsychotic drugs: A specific neuroleptic action

S. Hirsch, J. Belleroche, I. Das, 1990, Schizophrenia Research.

The relationship of spinal muscular atrophy to motor neuron disease: Investigation of SMN and NAIP gene deletions in sporadic and familial ALS

Richard W. Orrell, J. Belleroche, R. Orrell, 1997, Journal of the Neurological Sciences.

Drink, Drugs and Dependence: From Science to Clinical Practice

J. Belleroche, W. Caan, 2002 .

Treatment options across the addictions

J. Belleroche, W. Caan, 2002 .

The nature of heroin and cocaine dependence

J. Belleroche, W. Caan, 2002 .

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Analysis of muscarinic receptor concentration and subtypes following lesion of rat substantia innominata

I. M. Gardiner, J. Belleroche, N. Birdsall, 1985, Brain Research.

Differential temporal patterns of expression of immediate early genes in cerebral cortex induced by intracerebral excitotoxin injection: Sensitivity to dexamethasone and MK-801

J. Belleroche, Y. Collaço-Moraes, 1995, Neuropharmacology.

Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA

J. Belleroche, L. Virgo, 1995, Brain Research.

ZINC, GLUTAMATE RECEPTORS, AND MOTONEURONE DISEASE

J. Belleroche, F. Rose, 1987, The Lancet.

Inositol phosphate formation in chemotactic peptide-activated neutrophils obtained from normal and schizophrenic subjects

S. Hirsch, J. Belleroche, M. A. Essali, 1989 .

Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652

Lee, Duchen, Izzo, 2016 .

The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients

J. Belleroche, A. Al-Chalabi, C. Shaw, 2015, Neurobiology of Aging.

The role of d-amino acids in amyotrophic lateral sclerosis pathogenesis: a review

J. Belleroche, P. Paul, Praveen G. Paul, 2012, Amino Acids.

Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function

M. Barnes, P. Maycox, M. Lennon, 2010, Molecular Psychiatry.

Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10)

J. Belleroche, N. Lindefors, O. Zachrisson, 2006, Brain Research.

The Biochemistry of Coma

J. Belleroche, F. Rose, 1994 .

A Pivotal Role for Glutamate in the Pathogenesis of Schizophrenia, and Its Cognitive Dysfunction

S. Hirsch, J. Belleroche, L. Garey, 1997, Pharmacology Biochemistry and Behavior.

Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens

J. Belleroche, I. Kilpatrick, N. Birdsall, 1982, Brain Research.

TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

Xun Hu, Kelly L. Williams, Christopher E. Shaw, 2008, Science.

Stimulation of inositol phosphate production by propranolol in human neutrophils

S. Hirsch, J. Belleroche, I. Das, 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

Xun Hu, Kelly L. Williams, Christopher E. Shaw, 2009, Science.

Amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes

J. Belleroche, L. Montibeller, J. de Belleroche, 2018, Cell Stress and Chaperones.

Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis

Robert H. Brown, M. Weale, F. Baas, 2017, Science Translational Medicine.

A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia

H. Horvitz, J. De Belleroche, J. Belleroche, 2006, Neurology.

Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex

S. Hirsch, J. Belleroche, Steven R. Hirsch, 1996, Biological Psychiatry.

AMINO ACIDS IN SYNAPTIC VESICLES FROM MAMMALIAN CEREBRAL CORTEX: A REAPPRAISAL

J. Belleroche, H. Bradford, J. de Belleroche, 1973, Journal of neurochemistry.

Amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes

J. Belleroche, L. Montibeller, J. de Belleroche, 2018, Cell Stress and Chaperones.

Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia

S. Hirsch, A. Mortimer, T. Barnes, 1995, Biological Psychiatry.

Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain.

S. Hirsch, J. Belleroche, B. Puri, 1995, Biochemical and biophysical research communications.

Presence of a nitric oxide synthase inhibitor in schizophrenic subjects plasma

S. Hirsch, J. Belleroche, B. Puri, 1995, Schizophrenia Research.

Circulating l-arginine metabolites and platelet nitric oxide synthase in schizophrenics

S. Hirsch, J. Belleroche, B. Puri, 1995, Schizophrenia Research.

Allelic variants in the zinc transporter-3 gene, SLC30A3, a candidate gene identified from gene expression studies, show gender-specific association with schizophrenia

P. McKenna, A. Mortimer, J. Belleroche, 2014, European Psychiatry.

Excitotoxins induce ornithine decarboxylase activity in the rat central nervous system

J. Belleroche, L. Reed, 1989 .

Biochemical Changes Following Lesion of the Substantia innominata of the Rat: a Model for Alzheimer’s Disease

I. M. Gardiner, J. Belleroche, M. Hamilton, 1985 .

Plasma polyamine oxidase in normal and schizophrenic subjects

S. Hirsch, J. Belleroche, R. Richardson-Andrews, 1990, Schizophrenia Research.

Regional specificity of changes in the expression of NMDA receptor and cholecystokinin MRNA in schizophrenia

S. Hirsch, A. Mortimer, J. Belleroche, 1998, Schizophrenia Research.

Contrasting effects of 5-hydroxytryptamine on the release of dopamine and acetylcholine in the nucleus accumbens of rat

I. M. Gardiner, J. Belleroche, 1982, Journal of Neural Transmission.